/Companies

Oncology

venture arm · Oncology Ventures

14 known investors

Find your way into Oncology

Sign up to see every warm intro you have to Oncology

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Oncology team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Oncology Ventures is a cancer-focused venture capital fund that invests in healthcare technology startups related to oncology care. It backs companies across value-based oncology, digital health, and cancer treatment models.

Founders & leadership

BFBen Freeberg
Ben FreebergFounder, Managing PartnerBen Freeberg is founder and managing partner of Oncology Ventures, a venture capital firm investing in healthcare data companies addressing cancer care challenges, and previously served as a venture partner at Alpha Partners.
JF
Jay FreebergChief Financial Officer

Investors · 14

Also in the syndicate · 2

a16z Bio + HealthMorgan Healthlead

Funding

SEC filings, press & company announcements

$225M disclosed across 1 of 2 rounds · 2026

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Oncology do?
Oncology Ventures is a cancer-focused venture capital fund that invests in healthcare technology startups related to oncology care. It backs companies across value-based oncology, digital health, and cancer treatment models.
Who founded Oncology?
Oncology was founded by Ben Freeberg.
Who are Oncology's investors?
Oncology's investors include Sandwich Capital, AlleyCorp, Canaan Partners, Concord Health Partners, CVS Health Ventures, Forbion, Foresite Capital, Frist Cressey Ventures and 4 more.
How much funding has Oncology raised?
Oncology has disclosed $225M raised across 1 of its 2 known rounds.